Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLPG1205 drug-drug interaction study with metformin or rosuvastatin in healthy men
NL-OMON44647Phase 1Active, not recruiting
- Sponsor
- Galapagos NV
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of GLPG1205, metformin and rosuvastatin (2 cohorts), sponsored by Galapagos NV. Primary endpoints: Metformin pharmacokinetics and Rosuvastatin pharmacokinetics. Started Sep 2017; status: active, not recruiting.
02
Drugs
GLPG1205metforminrosuvastatin
Beyond the preview
Go deeper on NL-OMON44647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44647.